Share
 
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
13:00
TUPDB0101
Assessment of the World Health Organization early warning indicators of HIV drug resistance in Namibia for public health action, 2015
Steven Hong, Tufts Medical Center, United States
Abstract
Slides
13:05
TUPDB0102
High prevalence of antiretroviral drug resistance among HIV-infected pregnant women in Buenos Aires, Argentina
Diego Martin Cecchini, Hospital Cosme Argerich, Argentina
Abstract
Slides
13:10
TUPDB0103
HIV-1 drug resistance and genetic diversity in ART-naïve patients infected in 2013-2015 in Kazakhstan
Natalya Dzissyuk, Republican Center for Prevention and Control of AIDS, Kazakhstan
Abstract
13:15
TUPDB0104
Cross-sectional assessment of virological failure, drug resistance and third-line regimen requirements among patients receiving second-line ART in 3 large HIV programmes in Kenya, Malawi and Mozambique
Birgit Schramm, Epicentre, France
Abstract
13:20
TUPDB0105
Effect of PI resistance mutations on viral load in patients on PI monotherapy
Jennifer A Thompson, University College London, United Kingdom
Abstract
13:25
TUPDB0106
Dolutegravir plus rilpivirine in suppressed heavily pre-treated HIV-infected patients
Santiago Moreno, Ramon y Cajal University Hospital, Spain
Abstract
Slides
13:30
TUPDB0107
Moderated discussion